期刊文献+

造影剂肾病的危险因素及防治进展 被引量:5

原文传递
导出
摘要 随着造影剂在诊断和介入诊治术中的广泛应用,造影剂肾病(CIN)已成为当前医院内发生急性肾功能衰竭的第3位常见原因。了解CIN发病的危险因素及防治有助于识别高危患者、采取正确的预防措施、及时诊断和治疗,降低发病率及死亡率。
出处 《国际泌尿系统杂志》 2007年第4期559-562,共4页 International Journal of Urology and Nephrology
  • 相关文献

参考文献1

二级参考文献9

  • 1Liistro F, Falsini G, Bolognese L. The clinical burden of contrast media-induced nephropathy. Ital Heart J, 2003, 4(10):668-676.
  • 2Nash K, Hafeez A, Hou S. Hospital acquired renal insufficiency. Am J Kidney Dis, 2002, 39:930-936.
  • 3Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation, 2002, 105:2259-2264.
  • 4McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors,and relationship to mortality. Am J Med, 1997, 103:368-375.
  • 5Rudnick MR, Berns JS, Cohen RM, et al. Nephro-toxic risks of renal angiography: contrast media-associated nephrotoxicity ang atheroembolism-a critical review. Am J Kidney Dis, 1994, 24:713-727.
  • 6Cigarroa RG, Lange RA, Williams RH, et al. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med, 1989, 86:649-652.
  • 7Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med, 1990, 150:1237-1242.
  • 8Nikolsky E, Mehram R. Understanding the consequences of contrast-induced nephropathy. Reu Cardiovasc Med, 2003,4(Suppl 5):S10-S18.
  • 9Kini AS, Mitre CA, Kim M, et al. A protocal for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptoragonist fenoldopan. Catheter Cardiovasc Interv, 2002, 55:169-173.

共引文献28

同被引文献58

  • 1陈国兰,吴力源,赵小束.CT增强扫描中造影剂渗漏与注射速率的关系及处理[J].当代护士(中旬刊),2006,13(11). 被引量:26
  • 2蒙兰芬,龚智峰.造影剂肾病的研究进展[J].中国医学文摘(老年医学),2005,14(1):61-66. 被引量:9
  • 3Mac Eneaney PM,Dachm an AH.CT angiography in zhe evaluation of acture stroke.AJNR,1997,18:1011-1020.
  • 4Schweiger MJ,Chambers CE,Davidson CJ,et al.Prevention of contrast induced nephropathy:recommendations for zhe high risk patient undergoing cardiovasculor procedures.Catheter Cardiovasc Interv,2007,69:135-140.
  • 5Wong GT,Irwin MG. Contrast-induced nephrppathy.Br J Anaesth,2007,99:474-483.
  • 6Hange P,Schmitz-Rode T,Hubner D,et al.Reduction of contrast material dose and artifacts by a saline flush using a double-power injector in helical CT of the thorax.AJR,2000,174:1049-1053.
  • 7Call J,Sacrinty M,Applegate R,et al.Automated contrast injection in contemporary practice during cardiac catheter-ization and PCI:effects on contrast-induced nephropathy.Invasive Cardiol,2006,18:469-474.
  • 8Schweiger M J, Chambers CE, Davidson C J, et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures[ J]. Catheter Cardiovasc Interv,2007,69 ( 1 ) :135-140.
  • 9Stacul F. Reducing the risks for contrast - induced nephropathy [ J ]. Cardiovasc Intervent Radiol, 2005,28 ( Suppl 2) :12-18.
  • 10Weisbord SD, Palevsky PM. Radiocontrast- induced acute renal failure [ J ]. Intensive Care Med, 2005,20 ( 2 ) : 63-75.

引证文献5

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部